CTRI/2021/04/033188招募中3 期
A Prospective, Open Label, Randomized, controlled Clinical Study to Evaluate the Safety and Efficacy Of Cardamom-based capsules In Mild to Moderate Covid-19 Adult Patients.
Zum Heilen Diagnostic and Therapeutics Pvt Ltd0 个研究点目标入组 120 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subjects aged 18-65 years of age and of either sex
- •2. Subjects who are willing to give consent to the study
- •3. COVID-19 positive clinical symptoms and (subsequently) confirmed by the
- •current recommended confirmatory test (RT-PCR).
- •4. Mild to Moderate disease (NEWS score Less than/equal to 8)
- •5. Can take oral medicines
- •6. Subject willing to abide by and comply with the study protocol
排除标准
- •Age less than 18 years and more than 65 years
- •2. Pregnancy and lactation
- •3. Severe or complicated course of COVID-19 disease
- •4. Presence of acute hypoxic respiratory failure
- •Any uncontrolled systemic disease, infection
- •6. Those with serious Cardiovascular, Cerebrovascular, Respiratory, Liver or
- •Renal disease or any other disorder.
- •7. Other conditions, which in the opinion of the investigators makes the patient
- •unsuitable for enrolment or could interfere in adherence to of the study protocol
研究者
相似试验
进行中（未招募）
1 期
Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney TransplantatioEUCTR2016-001043-39-Outside-EU/EEAF. Hoffmann-La Roche AG720
招募中
3 期
Cardamom Extract Clinical trial on Covid patientsCTRI/2021/01/030601Zum Heilen Diagnostic Therapeutics ZH DT
尚未招募
3 期
Clinical trial on post covid patientsCTRI/2022/07/043655Zum Heilen Diagnostic and Therapeutics Pvt Ltd
已完成
3 期
A study of hormones in infertile women undergoing IVFCTRI/2019/10/021801Sanzyme P Ltd156
已完成
不适用
A prospective, open label, randomized, controlled trial of tocilizumab versus cyclophosphamide in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011244Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology40